Clinical Trial

Corheart 6 LVAS Study

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the safety and effectiveness of the Corheart 6 LVAS when used for the treatment of advanced left ventricular heart failure in a European population at 6 months post-implantation. The secondary objective is to assess the long-term safety and effectiveness of Corheart 6 LVAS treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-05-16; most recent amendment 2026-01-06.
Status change: Not Yet Recruiting → Recruiting 2024-06-29
Trial Details
NCT Number NCT05876000
Lead Sponsor Shenzhen Core Medical Technology CO.,LTD.
Conditions Refractory Heart Failure
Enrollment 53 participants
Start Date 2024-05-14
Primary Completion 2026-12-30 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-08